IL6 and cancer: Certain anti-cytokines are in drug trials such as MAbetaP 1 which is an immunoglobulin G developed against IL-1, clazakizumab against IL-6, and 7E which is an anti-monoclonal antibody against IL-20 are under development for the treatment of cancer cachexia targeting various cytokines involved in its pathology [33,34,38].